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Abstract. An eleven year-old mongrel dog was referred with 
a history of left forelimb lameness and an ulcerated mass on 
the neck. Histologically, the cutaneous neoplasm revealed 
cystic lobules composed of basaloid cells with abrupt tran-
sition to central keratotic material, containing pycnotic and 
shadow cells. Approximately 3 months after primary diag-
nosis, a lesion of the cortical bone on the left humerus was 
observed using X-ray. Samples obtained from the humerus 
were processed for histopathological examination and the 
neoplastic tissue was observed to be similar to the type 
identified in the neck. Based on these findings, the tumor 
was diagnosed as a malignant pilomatricoma (MP) with bone 
metastasis. MP is a rare skin tumor that originates from hair 
matrix cells. To date, only nine reports have been presented 
in dogs. In the present study, we discuss the cytological and 
histological patterns of MP, confirmed by immunohistochem-
istry using β catenin antibody. 
Introduction
Pilomatricoma is a benign adnexal neoplasm with follicular 
differentiation similar to matrical cells of the hair bulb, which 
occurs in middle-aged to older dogs (2-7 years of age) with 
normal gender distribution (1-5). Pilomatricoma manifests as 
an asymptomatic dermal or subcutaneous mass with alopecia 
of overlying skin, usually situated on the scalp, posterior 
area of the neck, buttocks and on the upper extremities (6,7). 
Breeds with continuous hair growth (Kerry Blue Terriers, 
Poodles, Bedlington Terriers, Bichon Frisés and Schnauzers) 
have higher susceptibility due to the greater mitotic activity 
of their hair follicles (7). Although benign pilomatricoma is 
a relatively frequent adnexal tumor (3% of all epithelial skin 
tumors) the incidence of its malignant counterpart [matrical 
carcinoma or malignant pilomatricoma (MP)] is extremely 
low (7-9). To the best of our knowledge, only nine reports 
of MP have been reported thus far in dogs (10-17), most of 
which presented metastasis in bone (10,12-16). The localiza-
tion and the clinical features of MP are similar to that of its 
benign counterpart, with the exception of its tendency to recur 
following incomplete excision and to metastasize to the under-
lying bone through contiguity or to distant sites (7).
Case report
An eleven year-old male mongrel dog was referred with a 
history of a left forelimb lameness, treated with non-steroidal 
anti-inflammatory drugs, without improvement. On physical 
examination, a painful zone near the left elbow was observed, 
without any abnormality demonstrated by radiography. An 
ulcerated mass on the neck was also detected. The mass was 
4 cm in diameter, well circumscribed, firm and not painful on 
palpation. Cytological examination of samples obtained by fine 
needle aspiration showed small cohesive epithelial aggregates 
composed of basaloid cells, a small amount of amorphous kera-
tinized material and a few ghost cells. Due to these findings, an 
initial diagnosis of a follicular tumor with matrical differentia-
tion was made. The mass was excised under general anesthesia, 
fixed in 10% formalin and routinely processed for histopatho-
logical examination. Microscopic examination revealed an 
epithelial neoplasia localized in the dermis and subcutaneous 
tissue, without connection to the overlying epidermis. The 
tumor was characterized by irregular cystic lobules, within 
which neoplastic cells were arranged in a circular configura-
tion, with nucleated basaloid-type cells on the periphery and 
pink amorphous keratin with enucleated shadow cells in the 
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centre (Fig. 1A). There was an abrupt transition between the 
basaloid cells and the central core. The basaloid cells had 
large, vesicular, hyperchromatic nuclei with prominent nucleoli 
and a moderate amount of clear cytoplasm and the centrally 
located cells showed well-delineated cell borders and a central 
unstained area corresponding to the lost nucleus (Fig. 1B). 
Scattered throughout the basaloid cell layer, 3-4 mitotic figures 
were observed at high power field (x400 magnification), some 
of which were atypical. In certain areas inflammatory cells, 
including mainly lymphocytes, plasma cells, macrophages 
and foreign body giant cells, were observed. The histological 
features were consistent with an MP.
To better define the matrical differentiation of this tumor, 
immunohistochemistry was performed by the streptav-
idin-biotin peroxidase complex method using a commercially 
available antibody against β catenin (monoclonal mouse 
anti-human, clone E-5, sc-7963; Santa Cruz Biotechnology, 
Heidelberg, Germany). The reaction of β catenin in the 
neoplastic tissue was observed in the cytoplasm of certain 
centrally located well-differentiated keratinocytes and in the 
nuclei of some of the basaloid cells. In the overlying epidermis 
that served as a control, β catenin was shown to be expressed 
in the keratinocytes in a perimembranous pattern (Fig. 1C). 
After one month the dog presented with a severe lame-
ness in the same left limb. Radiography of the elbow showed 
a severe permeative osteolysis with a long transitional zone 
of the distal epiphysis of the left humerus (Fig. 1D). A bone 
biopsy was performed and a neoplastic lesion similar to those 
Figure 1. Microscopic, X-ray and CT images of malignant pilomatricoma with bone metastases. (A) Skin from the neck of the dog. Microscopic view of the 
primary skin lesion: irregular lobules composed of proliferating basaloid cells organized around ghost cells (hematoxylin and eosin staining). (B) Higher 
magnification of (A); basaloid cells with pleomorphism, vesicular nuclei and prominent nucleoli (hematoxylin and eosin staining). (C) Skin from the neck 
of the dog. Irregularly distributed β catenin immunoreactivity in the cytoplasm of basaloid cells along the central cyst (arrows) and scattered positive nuclei 
(arrowheads; immunohistochemical method: streptavidin-biotin peroxidase). (D) Lateral X-ray view of left elbow. Marked permeative osteolysis with severe 
soft tissue enlargement on the distal humerus. (E) Metastatic lesion of the humerus. A high proportion of atypical basaloid cells associated with a ghost cell 
aggregate (left side) and bone lysis (right side; hematoxylin and eosin staining). (F) Transverse post-contrast CT scan, taken at level of the iliac crests. On the 
right crest, there is disomogeneous soft tissue mass, with mineralized spots, periosteal interrupted proliferations and moth-eaten osteolysis (arrows).
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described for the primary cutaneous tumor was observed. Due 
to these staging results, amputation was performed. A nodular 
bone mass was observed on the excised bone. The entire bone 
mass, which was 4 cm in diameter, white and friable, was 
fixed in 10% formalin for histopathology. Upon microscopic 
examination, performed following the routine procedure for 
decalcification, a neoplasia similar to the type identified in the 
primary skin mass was observed. It was confined to the bone 
with associated areas of bone lysis, mineralization, chondroid 
and osseous metaplasia (Fig. 1E). Compared with the primary 
tumor, there were larger areas of necrosis and a greater propor-
tion of basaloid cells, which showed more severe atypical 
features. Immunohistochemical findings using the β catenin 
antibody showed the presence of scattered cells with cyto-
plasmic positivity and nuclear staining in the majority of the 
basaloid cells. All the results derived from clinical, surgical, 
histological and immunohistochemical investigations strongly 
supported the diagnosis of a metastatic MP. 
The first five-month follow-up was excellent but, one 
month later, the dog presented again due to hind limb lame-
ness and skin lesions. On clinical evaluation, multiple palpable 
masses were appreciable on the skin of the right forehead, the 
skin of the left mandible, right humerus, left ribs (from third 
to seventh), right ileus, right femur, left knee and both tarsi. 
All the lesions were CT scanned and were characterized by 
a dishomogeneous pattern with mineralized spots, periosteal 
interrupted proliferations and moth-eaten osteolysis (Fig. 1F). 
No lung or abdominal metastasis was appreciable by thoracic 
radiography and abdominal ultrasonography, respectively. 
Due to the extremely poor prognosis, euthanasia but not 
necropsy was permitted by the owner. 
Discussion
The histopathological features of pilomatricoma are charac-
terized by irregularly shaped, lobulated islands of a dual cell 
population of basaloid cells and shadow or ghost cells, which 
represent keratinized immature hair cells. Within the lobules, 
an abrupt keratinization from basaloid to shadow cells is char-
acteristic of this neoplasia (3,5). 
Histologically, the criteria for malignancy in the differ-
ential diagnosis between MP and its benign counterpart 
are the presence of an encapsulated asymmetric ulcerated 
tumor growth, increased mitotic figures with nuclear atypical 
features, infiltration of the adjacent skin and lymphatic inva-
sion at the periphery of the mass (3,7,8).
Since almost all the above histological findings were 
observed in the present case, the diagnosis of MP was 
made. The malignant behavior of the tumor was confirmed 
subsequently by the detection of multiple bone metastases. 
In addition, immunohistochemical reactivity to β catenin 
confirmed the diagnosis of MP.
β catenin is a 92-kDa-sized cytoplasmic protein, involved 
in intercellular adhesion and the Wnt-signaling pathway. 
The cellular localization of β catenin is determined by its 
phosphorylation state. At the cell surface, as a subunit of 
the cadherin complex, it interacts with E cadherin, linking 
it to the actin cytoskeleton to create the cell-cell adherens 
junctions. When this protein is free in the cytosol, it is 
constitutively phosphorylated and directed to the nucleus for 
destruction (18). Deregulation of the Wnt/β catenin pathway, 
attributable to abnormalities of CTNNB1, the gene encoding 
β catenin, has been recognized to prevent phosphorylation of 
β catenin, resulting in its accumulation in the nucleus. At the 
nucleus, β catenin interacts with Tcf/Lef transcription factors 
to provide a stimulus for cell proliferation and differentiation, 
and most likely for neoplastic transformation (19). Numerous 
human studies have demonstrated that mutation of CTNNB1 
is a frequent cause of Wnt signaling pathway activation in 
pilomatricoma (20,21).
In skin tumors the variability of membrane, cytoplasmic 
and nuclear staining of β catenin is great, however, in 
pilomatricoma and its malignant counterpart an intense and 
diffuse nuclear pattern in the proliferating matrix (basaloid) 
cells is the main finding in the majority of the literature (22). 
In the present case we observed a predominant nuclear 
staining of β catenin in basaloid cells, while a few transitional 
cells showed a prevalent membrane-associated reactivity.
In conclusion, this study documents a case of canine MP 
and raises awareness of the potential aggressiveness of matrical 
tumors. In addition, the immunohistochemical observations 
suggest that β catenin is involved in the pathogenesis of this 
canine neoplasm and may be a useful diagnostic marker for 
MP in dogs, as previously demonstrated in humans. 
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